| Document Type
|
:
|
BL
|
| Record Number
|
:
|
1018042
|
| Doc. No
|
:
|
b772412
|
| Main Entry
|
:
|
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans(2005 :, Lyon, France)
|
| Title & Author
|
:
|
Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy.
|
| Publication Statement
|
:
|
Lyon, France :: International Agency for Research on Cancer ;Geneva :: Distributed by WHO Press,, 2007.
|
| Series Statement
|
:
|
IARC monographs on the evaluation of carcinogenic risks to humans ;; v. 91
|
| Page. NO
|
:
|
1 online resource (ix, 528 pages) :: illustrations
|
| ISBN
|
:
|
1281829617
|
|
|
:
|
: 661182961X
|
|
|
:
|
: 9240683216
|
|
|
:
|
: 9781281829610
|
|
|
:
|
: 9786611829612
|
|
|
:
|
: 9789240683211
|
|
|
:
|
9283212916
|
|
|
:
|
9789283212911
|
| Notes
|
:
|
"This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005."
|
|
|
:
|
At head of title: World Health Organization, International Agency for Research on Cancer.
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and cumulative index.
|
| Contents
|
:
|
Preliminaries; CONTENTS; PREAMBLE; Combined Estrogen-Progestogen Contraceptives; Combined Estrogen-Progestogen Menopausal Therapy; ANNEXES; CUMULATIVE INDEX TO THE MONOGRAPHS SERIES
|
| Abstract
|
:
|
Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960s. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future. This ninety-first volume of IARC Monograp.
|
| Subject
|
:
|
Cancer-- Risk factors.
|
| Subject
|
:
|
Catechol estrogens-- Carcinogenicity.
|
| Subject
|
:
|
Catechol estrogens-- Side effects.
|
| Subject
|
:
|
Chemical carcinogenesis.
|
| Subject
|
:
|
Contraception-- Complications.
|
| Subject
|
:
|
Estrogen-- Carcinogenicity.
|
| Subject
|
:
|
Estrogen-- Side effects.
|
| Subject
|
:
|
Menopause-- Hormone therapy-- Complications.
|
| Subject
|
:
|
Oral contraceptives-- Carcinogenicity.
|
| Subject
|
:
|
Progestational hormones-- Carcinogenicity.
|
| Subject
|
:
|
Progestational hormones-- Side effects.
|
| Subject
|
:
|
Women-- Diseases-- Risk factors.
|
| Subject
|
:
|
Carcinogens.
|
| Subject
|
:
|
Contraceptives, Oral, Combined-- adverse effects.
|
| Subject
|
:
|
Contraceptives, Oral, Hormonal-- adverse effects.
|
| Subject
|
:
|
Estrogens-- adverse effects.
|
| Subject
|
:
|
Estrogens-- therapeutic use.
|
| Subject
|
:
|
Hormone Replacement Therapy-- adverse effects.
|
| Subject
|
:
|
Neoplasms-- chemically induced.
|
| Subject
|
:
|
Neoplasms-- prevention control.
|
| Subject
|
:
|
Progestins-- adverse effects.
|
| Subject
|
:
|
Progestins-- therapeutic use.
|
| Subject
|
:
|
Cancer-- Risk factors.
|
| Subject
|
:
|
Chemical carcinogenesis.
|
| Subject
|
:
|
Contraception-- Complications.
|
| Subject
|
:
|
HEALTH FITNESS-- Diseases-- Cancer.
|
| Subject
|
:
|
MEDICAL-- Oncology.
|
| Subject
|
:
|
Menopause-- Hormone therapy-- Complications.
|
| Subject
|
:
|
Oral contraceptives-- Carcinogenicity.
|
| Dewey Classification
|
:
|
616.994071
|
| LC Classification
|
:
|
RC268.7.O72I19 2007eb
|
| NLM classification
|
:
|
QZ 202I103c 2007
|
|
|
:
|
W1IA21I v.91 2007
|
| Added Entry
|
:
|
International Agency for Research on Cancer.
|
|
|
:
|
World Health Organization.
|